TP53 and Burkitt lymphoma: EBV-associated hypermethylation affected regulatory regions of genes frequently mutated in BL (e.g., CCND3, TP53) and impacted super-enhancers, suggesting that hypermethylation may compensate for the lower mutational burden of pathogenic drivers in EBV-positive BL [84].